Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of bimatoprost for female pattern hair loss in women; the trial is completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Female Pattern Hair Loss

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Alopecia, Baldness | Phase 2 | Status: COMPLETED | Results posted: 2014-04-09